New Resource Harmonizes 16S and Shotgun Sequencing Data for Microbiome Research
July 27, 2023
UC San Diego scientists debut Greengenes2, a massive reference database that could be used to reconcile years of microbiome studies.
Your search for “Infectious disease” returned 331 results
Groundbreaking Research Paves the Way for Acne Vaccine
December 20, 2023
In a groundbreaking development in the field of anti-acne therapies, a team of researchers has created an acne vaccine that, when used in a mouse acne model, neutralizes a specific variant of an enzyme produced by an acne-associated bacteria while leaving the healthy bacterial enzyme intact.
Nanoengineers Receive $4.3M From NIH To Continue Studies Using Plant Viruses To Treat Cancer
October 17, 2022
Researchers led by Nicole Steinmetz, professor of nanoengineering at the University of California San Diego, have received $4.3 million in grants from the National Institutes of Health (NIH) to advance their research using plant viruses to develop cancer immunotherapies.
UC San Diego Receives $16 Million NIH FIRST Award
September 20, 2022
The UC San Diego FIRST Program will recruit 12 diverse, early-career research faculty in the biomedical sciences and the implement strategies to improve faculty recruitment, retention, success and inclusion.
Why the Flu Vaccine Is Less Effective in the Elderly
December 15, 2015
Around this time every year, the flu virus infects up to one-fifth of the U.S. population and kills thousands of people, many of them elderly. A study published by Cell Press on Dec. 15 in Immunity now explains why the flu vaccine is less effective at protecting older individuals. More…
For ME/CFS Patients, Viral Immunities Come at a Devastating, Lifelong Cost
April 27, 2020
Researchers at UC San Diego School of Medicine and three German universities describe an underlying biological basis for myalgic encephalomyelitis/chronic fatigue syndrome, illustrating how efforts by the body to boost immune system protections can come at physiological cost elsewhere.
Paper Calls for Patient-First Regulation of AI in Healthcare
January 31, 2024
A new paper in JAMA describes how, despite widespread enthusiasm about AI’s potential to revolutionize healthcare and the use of AI-powered tools on millions of patients already, no federal regulations require that AI-powered tools be evaluated for potential harm or benefit to patients.
Meet Dr. Brookie Best, Dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences
August 11, 2022
…used to treat Kawasaki disease, the leading cause of acquired heart disease in children. She has authored more than 130 peer-reviewed papers, lectured on maternal and pediatric drug therapeutics at the National Institute of Allergy and Infectious Diseases and served on working groups and advisory committees for the National Institutes…
HIV Incidence Rising Steeply Among People Who Inject Drugs in Tijuana
February 11, 2022
Researchers at UC San Diego School of Medicine have presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by “drug tourism” unabated by the closure of the international border due to the COVID-19 pandemic.
How SARS-CoV-2 Went from Single Cases to Overwhelming Continents
September 16, 2020
Early detection and intervention stanched the first known introductions of the SARS-CoV-2 virus into North America and Europe, validating the effectiveness of quick, comprehensive testing and contact tracing, but inadequate public health measures allowed the virus to take hold.
